Back to Agenda
Digital Technology Advances Labeling Management and Patient Access
Session Chair(s)
Fengyun(Vicky) Han
Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
This session will update the labeling management across regions in the EU and the Asia Pacific, in particular, the NMPA and PMDA will elaborate on current labeling management in China and Japan and envisage digital/electronic labeling management in the future. Also, the industry will share some industry initiated eLabeling pilot activities, finally, all will discuss the opportunities and hurdles of introducing digital/electronic labeling
Learning Objective : Explain digital/electronic labeling policy and its pilot activities across different regions; Discuss the advantages of digital/electronic labeling and benefit to patients and prescribers; Describe the latest eLabeling policy and future trends in EU and the Asia Pacific, particularly in Japan and China
Speaker(s)
Labeling Management Update from the PMDA
Mariko Tsukuda, MSc
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of Pharmacovigilance I
NMPA Labeling Management and Envisage of Electronic Labeling Trends in China
Xiaoyuan Chen, PhD
Beijing Tsinghua Changgung Hospital, China
Director, GCP Officer
Digital Labeling Innovation in Europe
Shimon Yoshida, PhD
Pfizer Inc, United Kingdom
Executive Director, International Labeling Group, Global Regulatory Affairs
Trends of eLabeling and its Innovation Pilot Activities in Asia Pacific
Fengyun(Vicky) Han
Johnson & Johnson Pte. Ltd., Singapore
Senior Director, Head of Regulatory Policy for Asia Pacific
Have an account?